Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy (Q45165261)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 November 2004

Language	Label	Description	Also known as
English	Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy	scientific article published on 26 November 2004

Statements

scholarly article

1 reference

Europe PubMed Central

10 December 2017

Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy (English)

1 reference

Europe PubMed Central

10 December 2017

author name string

Judith A F Huirne

1

1 reference

Europe PubMed Central

10 December 2017

Andre C D van Loenen

2

1 reference

Europe PubMed Central

10 December 2017

Roel Schats

3

1 reference

Europe PubMed Central

10 December 2017

Joseph McDonnell

4

1 reference

Europe PubMed Central

10 December 2017

Peter G A Hompes

5

1 reference

Europe PubMed Central

10 December 2017

Joop Schoemaker

6

1 reference

Europe PubMed Central

10 December 2017

Roy Homburg

7

1 reference

Europe PubMed Central

10 December 2017

Cornelis B Lambalk

8

1 reference

Europe PubMed Central

10 December 2017

language of work or name

0 references

publication date

26 November 2004

1 reference

Europe PubMed Central

10 December 2017

Human Reproduction

1 reference

Europe PubMed Central

10 December 2017

20

1 reference

Europe PubMed Central

10 December 2017

2

1 reference

Europe PubMed Central

10 December 2017

359-367

1 reference

Europe PubMed Central

10 December 2017

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

GnRH antagonist in assisted reproduction: a Cochrane review

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Is luteinizing hormone needed for optimal ovulation induction?

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Role of LH and FSH in ovarian function

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Gonadotropin-releasing-hormone-receptor antagonists

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Dose-finding study of daily gonadotropin-releasing hormone (GnRH) antagonist for the prevention of premature luteinizing hormone surges in IVF/ICSI patients: antide and hormone levels

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Evidence for different aetiologies of low estradiol response to FSH: age-related accelerated luteinization of follicles or presence of ovarian autoantibodies

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Signal transduction mechanism for LH in the cumulus-oocyte complex

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Hypersecretion of luteinising hormone, infertility, and miscarriage

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Elevated serum progesterone level on the day of human chorionic gonadotropin administration does not adversely affect implantation rates after intracytoplasmic sperm injection and embryo transfer.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEH601

21 January 2018

Identifiers

10.1093/HUMREP/DEH601

1 reference

Europe PubMed Central

10 December 2017

1 reference

Europe PubMed Central

10 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45165261&oldid=2068775200"